Aerie Pharmaceuticals Mergers and Acquisitions Summary

Life Science Company

Aerie Pharmaceuticals has acquired 1 company, including 1 in the last 5 years.

Aerie Pharmaceuticals’ largest acquisition to date was in 2019, when it acquired Avizorex Pharma SL for $10M. The Company’s most targeted sectors include life science (100%).

Join Mergr and gain access to Aerie Pharmaceuticals’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1

Aerie Pharmaceuticals, Inc.

4301 Emperor Boulevard Suite 400,
Irvine, California 27703
United States,
(919) 237-5300

Aerie Pharmaceuticals, Inc. is a clinical-stage biotechnology company dedicated to the discovery and development of novel treatments for glaucoma. Aerie Pharmaceuticals was formed in 2005 and is based in Irvine, California.

M&A Summary

Buy vs Sell

Year ≤ '16 '17 '18 '19 '20 '21 T
Buy (0.2/yr) # - - - 1 - - 1
vol $10M $10M
Sell (0.0/yr) # - - - - - - 0

Most Recent M&A

Company Date Value Type
Avizorex Pharma SL 2019-11-18 10M USD Add-on Acquisition
Barcelona, Spain ·
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) 10M (100%) - -
Total 1 $10M - -

By Geo

State/Country Buy Value Sell Value
Spain 1 10M - -
Total 1 $10M - -

Deal Values

buy # Total
< $100M 1 $10M
Largest Avizorex Pharma SL
$10M (2019-11-18)

 Subscribe to unlock this and 163,777
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 4.1K Private Equity Firms
  • 152K M&A Transactions
  • 160K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.2K M&A Advisors
    (Investment Banks and Law Firms)
  • 49K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.